Hong M, Kim JW, Kim MK, Chung BW, Ahn SK. Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome. J Cancer. 2020;11(24):7246-52.
Min BH, Hong M, Lee JH, Rhee PL, Sohn TS, Kim S, et al. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Br J Surg. 2018.
Lee SE, Hong M, Cho J, Lee J, Kim KM. IKKepsilon and TBK1 expression in gastric cancer. Oncotarget. 2017;8(10):16233-42.
Lee JY, Hong M, Lee J, Lee S, Kim KM, Park C, et al. An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients. J Cancer. 2017;8(5):730-6.
Hong M, Kim JW, Shin MK, Kim BC. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds. J Korean Med Sci. 2017;32(10):1595-602.
Lim SH, Hong M, Ahn S, Choi YL, Kim KM, Oh D, et al. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer. Eur J Cancer. 2016;52:1-9.
Hong M, Lee T, Young Kang S, Kim SJ, Kim W, Ko YH. Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior. Mod Pathol. 2016;29(5):430-43.
Lee JY, Hong M, Kim ST, Park SH, Kang WK, Kim KM, et al. The impact of concomitant genomic alterations on treatment outcome for trastuzumab therapy in HER2-positive gastric cancer. Sci Rep. 2015;5:9289.
Kim ST, Lee J, Hong M, Park K, Park JO, Ahn T, et al. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis. Oncotarget. 2015;6(32):33358-68.
Ji JH, Oh YL, Hong M, Yun JW, Lee HW, Kim D, et al. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. PLoS Genet. 2015;11(8):e1005467.
Hong M, Ko YH. CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder. J Pathol Transl Med. 2015;49(6):525-30.
Hong M, Kim WS, Ko YH. Indolent CD56-Positive Clonal T-Cell Lymphoproliferative Disease of the Stomach Mimicking Lymphomatoid Gastropathy. Korean J Pathol. 2014;48(6):430-3.
Hong M, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, et al. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. J Thorac Oncol. 2014;9(3):419-22.
Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, et al. EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood. Korean J Pathol. 2013;47(2):137-47